During the past decade, Wuxi No. 4 People's Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wuxi No. 4 People's Hospital" are "Solid Tumor, Adult" (3 trials), "Breast Cancer" (1 trials), "Breast Carcinoma" (1 trials), "Cancer of Head and Neck" (1 trials) and "Carcinoma, Bronchogenic" (1 trials). Many other conditions were trialed in "Wuxi No. 4 People's Hospital" in a lesser frequency.

Most popular intervention types in "Wuxi No. 4 People's Hospital" are "Drug" (6 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bismuth-Containing Quadruple Therapy" (2 trials), "Lansoprazole" (2 trials), "Lansoprazole Placebo" (2 trials), "TAK-438" (2 trials) and "TAK-438 Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wuxi No. 4 People's Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Wuxi No. 4 People's Hospital". 2 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wuxi No. 4 People's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wuxi No. 4 People's Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".